Happiness Biotech Group Ltd. (HAPP)
Stock Price Chart
Key Info
| Market Cap | 42.88M |
| Revenue (ttm) | 65.06M |
| Net Income (ttm) | 12.69M |
| Shares Out | 25.00M |
| EPS (ttm) | 0.80 |
| PE Ratio | 2.14 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 28, 2020 |
| Last Price | $1.72 |
| Previous Close | $1.74 |
| Change ($) | -0.03 |
| Change (%) | -1.44% |
| Day's Open | 1.70 |
| Day's Range | 1.65 - 1.73 |
| Day's Volume | 414,325 |
| 52-Week Range | 1.65 - 6.10 |
More Stats
| Market Cap | 42.88M |
| Enterprise Value | 11.25M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | Aug 7, 2020 |
| Shares Outstanding | 25.00M |
| Float | 8.88M |
| EPS (basic) | 0.53 |
| EPS (diluted) | 0.80 |
| FCF / Share | 0.40 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 46.65% |
| FCF Yield | 22.43% |
| Payout Ratio | n/a |
| Shares Short | 95,064 |
| Short Ratio | 0.17 |
| Short % of Float | 1.07% |
| Beta | n/a |
| PE Ratio | 2.14 |
| Forward PE | n/a |
| P/FCF Ratio | 4.46 |
| PS Ratio | 0.66 |
| PB Ratio | 0.57 |
| Revenue | 65.06M |
| Operating Income | 15.40M |
| Net Income | 12.69M |
| Free Cash Flow | 9.62M |
| Net Cash | 31.62M |
| Net Cash / Share | 1.26 |
| Gross Margin | 46.75% |
| Operating Margin | 23.67% |
| Profit Margin | 19.50% |
| FCF Margin | 14.78% |
| ROA | 12.77% |
| ROE | 18.06% |
| ROIC | 33.40% |
Analyst Forecasts
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 65.06 | 63.94 | 61.50 | 53.00 |
| Revenue Growth | 1.76% | 3.97% | 16.04% | - |
| Gross Profit | 30.42 | 32.25 | 29.35 | 25.82 |
| Operating Income | 15.40 | 21.84 | 20.24 | 17.21 |
| Net Income | 12.69 | 18.72 | 17.49 | 14.52 |
| Shares Outstanding | 23.84 | 23.00 | 23.00 | 23.00 |
| Earnings Per Share | 0.53 | 0.81 | 0.76 | 0.63 |
| EPS Growth | -34.57% | 6.58% | 20.63% | - |
| Operating Cash Flow | 10.78 | 6.54 | 12.93 | 11.32 |
| Capital Expenditures | -1.16 | -0.28 | -0.16 | -1.10 |
| Free Cash Flow | 9.62 | 6.27 | 12.78 | 10.22 |
| Cash & Equivalents | 33.65 | 14.80 | 8.88 | 4.27 |
| Total Debt | 2.03 | 1.04 | 1.49 | 1.95 |
| Net Cash / Debt | 31.62 | 13.76 | 7.39 | 2.32 |
| Assets | 85.10 | 65.68 | 53.40 | 41.53 |
| Liabilities | 5.51 | 4.76 | 8.84 | 18.21 |
| Book Value | 79.59 | 60.92 | 44.55 | 23.31 |
Company Profile
Company Details
| Full Name | Happiness Biotech Group Ltd. |
| Country | China |
| Employees | 151 |
| CEO | Xue Zhu Wang |
Stock Information
| Ticker Symbol | HAPP |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | NASDAQ: HAPP |
| IPO Date | October 25, 2019 |
Description
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the company provides disinfectants, non-medical face masks, and COVID-19 anti-body testing kits. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.